Mitsubishi Tanabe Pharma Corporation
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Masayuki_Mitsuka
|
| gptkbp:country |
gptkb:Japan
|
| gptkbp:founded |
1678
|
| gptkbp:headquarters_location |
gptkb:Osaka,_Japan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mitsubishi Tanabe Pharma Corporation
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:logo |
Mitsubishi Tanabe Pharma logo.svg
|
| gptkbp:mergedInto |
2007
|
| gptkbp:notableProduct |
gptkb:Remicade
gptkb:Edaravone |
| gptkbp:numberOfEmployees |
about 7,000
|
| gptkbp:officialWebsite |
https://www.mt-pharma.co.jp/
|
| gptkbp:parentOrganization |
gptkb:Mitsubishi_Chemical_Holdings
|
| gptkbp:predecessor |
gptkb:Mitsubishi_Pharma
gptkb:Tanabe_Seiyaku |
| gptkbp:products |
pharmaceutical drugs
|
| gptkbp:servesArea |
worldwide
|
| gptkbp:stockExchange |
gptkb:Tokyo_Stock_Exchange
|
| gptkbp:subsidiary |
gptkb:Mitsubishi_Tanabe_Pharma_America,_Inc.
|
| gptkbp:type |
public (K.K.)
|
| gptkbp:bfsParent |
gptkb:MTJ
|
| gptkbp:bfsLayer |
6
|